373 related articles for article (PubMed ID: 27473874)
1. Low-dose propranolol for infantile hemangioma of the head and neck: Analysis of 23 consecutive patients.
Ren W; Li S; Gao L; Huang S; Zhang L; Qiang C; Liu C; Zhi K
Pediatr Int; 2017 Feb; 59(2):213-217. PubMed ID: 27473874
[TBL] [Abstract][Full Text] [Related]
2. Low-dose propranolol regimen for infantile haemangioma.
Tan CE; Itinteang T; Leadbitter P; Marsh R; Tan ST
J Paediatr Child Health; 2015 Apr; 51(4):419-24. PubMed ID: 25187156
[TBL] [Abstract][Full Text] [Related]
3. Beta blocker treatment for infantile hemangiomas.
Rouhana HF; Fruge JH; Massengale WT
Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436966
[TBL] [Abstract][Full Text] [Related]
4. Preliminary experiences in treating infantile hemangioma with propranolol.
Chai Q; Chen WL; Huang ZQ; Zhang DM; Fan S; Wang L
Ann Plast Surg; 2014 Feb; 72(2):169-72. PubMed ID: 21629056
[TBL] [Abstract][Full Text] [Related]
5. Propranolol for infantile haemangioma: striking effect in the first weeks.
Katona G; Csákányi Z; Gács E; Szalai Z; Ráth G; Gerlinger I
Int J Pediatr Otorhinolaryngol; 2012 Dec; 76(12):1746-50. PubMed ID: 22944359
[TBL] [Abstract][Full Text] [Related]
6. Infantile hemangioma: treatment with short course systemic corticosteroid therapy as an alternative for propranolol.
Nieuwenhuis K; de Laat PC; Janmohamed SR; Madern GC; Oranje AP
Pediatr Dermatol; 2013; 30(1):64-70. PubMed ID: 22958179
[TBL] [Abstract][Full Text] [Related]
7. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
8. Propranolol for treatment of ulcerated infantile hemangiomas.
Saint-Jean M; Léauté-Labrèze C; Mazereeuw-Hautier J; Bodak N; Hamel-Teillac D; Kupfer-Bessaguet I; Lacour JP; Naouri M; Vabres P; Hadj-Rabia S; Nguyen JM; Stalder JF; Barbarot S;
J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332
[TBL] [Abstract][Full Text] [Related]
9. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.
Buckmiller LM; Munson PD; Dyamenahalli U; Dai Y; Richter GT
Laryngoscope; 2010 Apr; 120(4):676-81. PubMed ID: 20112413
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Radiological Evaluation of Periocular Infantile Hemangioma Treated With Oral Propranolol: A Case Series.
Ginguerra MA; Saito O; Fernandes JBVD; Castro DS; Matayoshi S
Am J Ophthalmol; 2018 Jan; 185():48-55. PubMed ID: 29103963
[TBL] [Abstract][Full Text] [Related]
11. Scoring the therapeutic effects of oral propranolol for infantile hemangioma: A prospective study comparing the Hemangioma Activity Score (HAS) with the Hemangioma Severity Scale (HSS).
Janmohamed SR; van Oosterhout M; de Laat PC; van Rosmalen J; Madern GC; Oranje AP
J Am Acad Dermatol; 2015 Aug; 73(2):258-63. PubMed ID: 26183969
[TBL] [Abstract][Full Text] [Related]
12. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
[TBL] [Abstract][Full Text] [Related]
13. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.
Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A
Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521
[TBL] [Abstract][Full Text] [Related]
15. Propranolol for problematic head and neck hemangiomas: an analysis of 37 consecutive patients.
Lv MM; Fan XD; Su LX
Int J Pediatr Otorhinolaryngol; 2012 Apr; 76(4):574-8. PubMed ID: 22326207
[TBL] [Abstract][Full Text] [Related]
16. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients.
Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N
Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601
[TBL] [Abstract][Full Text] [Related]
17. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls.
Hermans DJ; van Beynum IM; Schultze Kool LJ; van de Kerkhof PC; Wijnen MH; van der Vleuten CJ
J Am Acad Dermatol; 2011 May; 64(5):833-8. PubMed ID: 21353329
[TBL] [Abstract][Full Text] [Related]
18. Experience with Holter monitoring during propranolol therapy for infantile hemangiomas.
Jacks SK; Kertesz NJ; Witman PM; Fernandez Faith E
J Am Acad Dermatol; 2015 Aug; 73(2):255-7. PubMed ID: 26054433
[TBL] [Abstract][Full Text] [Related]
19. Treatment of problematic infantile hemangiomas with propranolol: a series of 40 cases and review of the literature.
Oksiuta M; Matuszczak E; Dębek W; Dzienis-Koronkiewicz E; Hermanowicz A; Tylicka M
Postepy Hig Med Dosw (Online); 2014 Sep; 68():1138-44. PubMed ID: 25228522
[TBL] [Abstract][Full Text] [Related]
20. High levels of β2-adrenoceptors are expressed in infantile capillary hemangiomas and may mediate the therapeutic effect of propranolol.
Hadaschik E; Scheiba N; Engstner M; Flux K
J Cutan Pathol; 2012 Sep; 39(9):881-3. PubMed ID: 22764832
[No Abstract] [Full Text] [Related]
[Next] [New Search]